Other OTC Pharmaceuticals - NAFTA

NAFTA

Highlights

In the year 2024, the revenue generated in the Other OTC Pharmaceuticals market in NAFTA amounts to US$7.73bn.
It is projected that this market will experience an annual growth rate of 0.95%, as measured by the Compound Annual Growth Rate (CAGR) from 2024 to 2029.
Among all countries, the United States stands out as the highest revenue generator, with US$7.17bn in 2024.
When considering the population size, the per person revenue in 2024 is estimated to be US$15.14.
The OTC pharmaceutical market in NAFTA countries is experiencing a surge in demand for alternative medicine products.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in NAFTA is witnessing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trend.Customer preferences play a crucial role in shaping the Other OTC Pharmaceuticals market in NAFTA. Consumers in this region are increasingly seeking self-care options for minor ailments and health concerns. They prefer over-the-counter medications that are easily accessible, affordable, and provide quick relief. This preference for self-care and convenience has led to a surge in demand for Other OTC Pharmaceuticals.Trends in the market further support the growth of the Other OTC Pharmaceuticals market in NAFTA. One notable trend is the increasing focus on preventive healthcare. Consumers are becoming more proactive in managing their health and are turning to OTC medications to address minor health issues before they escalate. This trend is driving the demand for a wide range of OTC pharmaceutical products, including pain relievers, cold and flu remedies, digestive health products, and vitamins and supplements.Another trend in the market is the growing popularity of natural and herbal remedies. Consumers are increasingly seeking products that are perceived as more natural and have fewer side effects. This has led to a rise in the demand for herbal and homeopathic OTC medications. Manufacturers are capitalizing on this trend by introducing a variety of natural and herbal products to cater to this consumer demand.Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals market in NAFTA. The aging population in this region is a significant factor driving market growth. As the population ages, the prevalence of chronic health conditions increases, leading to a higher demand for OTC medications to manage these conditions. Additionally, the high healthcare costs and limited access to healthcare services in some areas have further fueled the demand for affordable OTC pharmaceuticals.Underlying macroeconomic factors also play a role in the development of the Other OTC Pharmaceuticals market in NAFTA. The stable economic growth in the region has resulted in increased disposable income, allowing consumers to spend more on healthcare products, including OTC medications. Moreover, the increasing urbanization and changing lifestyles have contributed to the rise in health-consciousness among consumers, further driving the demand for OTC pharmaceuticals.In conclusion, the Other OTC Pharmaceuticals market in NAFTA is experiencing significant growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The preference for self-care, the focus on preventive healthcare, the popularity of natural and herbal remedies, the aging population, and the stable economic growth in the region are all contributing to the positive growth trajectory of this market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.